AstraZeneca (AZN) enters a settlement with Handa Pharmaceuticals in a patent infringement case...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN) enters a settlement with Handa Pharmaceuticals in a patent infringement case over Handa's proposed Seroquel extended-release tablets. Under the terms of the agreement, Handa can enter the U.S. market with the drug in November 2016 or earlier in certain circumstances.